Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, signaling a new patch release of the page. No visible content changes are indicated in the provided data.
    Difference
    0.1%
    Check dated 2026-08-30T15:49:56.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates an updated version of the study record.
    Difference
    0.0%
    Check dated 2026-08-09T09:19:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Software revision updated from v3.6.3 to v3.6.4, indicating a new site release. No visible changes to the study details content or page structure are shown.
    Difference
    0.0%
    Check dated 2026-07-25T17:59:15.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.3) was added and the previous tag (v3.6.2) removed, indicating a minor platform update; the visible study details and layout remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-04T13:33:46.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.0 to v3.6.2, indicating a minor site update to the study page. This reflects a version bump in the page's content rather than a change to the study data or eligibility.
    Difference
    0.0%
    Check dated 2026-06-27T06:41:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now includes an explicit recruitment update 'No longer looking for participants' and adds user guidance sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The header 'Intervention/Treatment' is introduced (replacing 'Intervention / Treatment'), and a 'Revision: v3.6.0' tag appears alongside removal of 'Revision: v3.5.5'.
    Difference
    0.4%
    Check dated 2026-06-13T01:07:56.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.